Showing 1 - 12 results of 12 for search 'Anna Lantz', query time: 0.04s
Refine Results
-
1
Social Determinants Predict Outcomes in Data From a Multi-Ethnic Cohort of 20,899 Patients Investigated for COVID-19 by Dara J. Lundon, Nihal Mohamed, Nihal Mohamed, Nihal Mohamed, Anna Lantz, Anna Lantz, Heather H. Goltz, Brian D. Kelly, Ashutosh K. Tewari, Ashutosh K. Tewari
Published 2020-11-01
Article -
2
-
3
Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer by Markus Arvendell, Lars Björnebo, Martin Eklund, Ugo Giovanni Falagario, Jan Chandra Engel, Olof Akre, Henrik Grönberg, Tobias Nordström, Anna Lantz
Published 2024-04-01
Article -
4
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression by Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Ugo Giovanni Falagario, Luigi Cormio, Giuseppe Carrieri
Published 2022-07-01
Article -
5
-
6
Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer by Elin Axén, Rebecka Arnsrud Godtman, Anders Bjartell, Stefan Carlsson, Eva Haglind, Jonas Hugosson, Anna Lantz, Marianne Månsson, Gunnar Steineck, Peter Wiklund, Johan Stranne
Published 2021-08-01
Article -
7
Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists by Zachary Dovey, Nihal Mohamed, Yasmine Gharib, Parita Ratnani, Nada Hammouda, Sujit S. Nair, Dimple Chakravarty, Stanislaw Sobotka, Anna Lantz, Peter Wiklund, Natasha Kyprianou, Ash Tewari
Published 2020-07-01
Article -
8
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer by Anna Lantz, Per Nordlund, Ugo Falagario, Fredrik Jäderling, Orhan Özbek, Mark Clements, Andrea Discacciati, Henrik Grönberg, Martin Eklund, Phillip Stricker, Mark Emberton, Markus Aly, Tobias Nordström
Published 2023-05-01
Article -
9
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation by Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Matteo Landriscina, Vincenza Conteduca, Ugo Giovanni Falagario, Luigi Cormio, Giuseppe Carrieri
Published 2022-07-01
Article -
10
A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer by Vinayak G. Wagaskar, Stanislaw Sobotka, Parita Ratnani, James Young, Anna Lantz, Sneha Parekh, Ugo Giovanni Falagario, Li Li, Sara Lewis, Kenneth Haines III, Sanoj Punnen, Peter Wiklund, Ash Tewari
Published 2021-08-01
Article -
11
Social Determinants Contribute to Disparities in Test Positivity, Morbidity and Mortality: Data from a Multi-Ethnic Cohort of 1094 GU Cancer Patients Undergoing Assessment for COVI... by Rebecca A. Moorhead, Jonathan S. O’Brien, Brian D. Kelly, Devki Shukla, Damien M. Bolton, Natasha Kyprianou, Peter Wiklund, Anna Lantz, Nihal Mohamed, Heather H. Goltz, Dara J. Lundon, Ashutosh Tewari
Published 2022-07-01
Article -
12
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with A... by Sneha Parekh, Parita Ratnani, Ugo Falagario, Dara Lundon, Deepshikha Kewlani, Jordan Nasri, Zach Dovey, Dimitrios Stroumbakis, Daniel Ranti, Ralph Grauer, Stanislaw Sobotka, Adriana Pedraza, Vinayak Wagaskar, Lajja Mistry, Ivan Jambor, Anna Lantz, Otto Ettala, Armando Stabile, Pekka Taimen, Hannu J. Aronen, Juha Knaapila, Ileana Montoya Perez, Giorgio Gandaglia, Alberto Martini, Wolfgang Picker, Erik Haug, Luigi Cormio, Tobias Nordström, Alberto Briganti, Peter J. Boström, Giuseppe Carrieri, Kenneth Haines, Michael A. Gorin, Peter Wiklund, Mani Menon, Ash Tewari
Published 2022-07-01
Article